Name | Smith & Nephew |
---|---|
Epic | SN. |
Isin | GB0009223206 |
Index | UK100 UK350 |
Industry | Medical Equipment and Services |
Latest share price | 1,025.50p | Net gearing | n/a |
---|---|---|---|
Market capitalisation | £8,966.85 | Debt ratio | n/a |
Shares in issue | 874.38 | Debt-to-equity ratio | n/a |
P/E ratio | 16.6 | Assets / equity ratio | n/a |
Total dividends per share | 14.40¢ | Price to book value | n/a |
Dividend yield | 2.7 | ROCE | 9.12 |
Dividend cover | 2.21 | EPS growth | 1 |
Earning per share | 30.2 | 52-week high / low | 917.60p / 1,208.50p |
Type | Ex-date | Pay-date | Net-dividend |
---|---|---|---|
Final | 2024-03-28 | 2024-05-22 | 23.10¢ |
Interim | 2023-10-05 | 2023-11-01 | 14.40¢ |
Final | 2023-03-30 | 2023-05-17 | 23.10¢ |
Interim | 2022-09-29 | 2022-10-26 | 14.40¢ |
Final | 2022-03-31 | 2022-05-11 | 23.10¢ |
Interim | 2021-09-30 | 2021-10-27 | 14.40¢ |
Final | 2021-04-01 | 2021-05-12 | 23.10¢ |
Interim | 2020-10-01 | 2020-10-28 | 14.40¢ |
Final | 2020-04-02 | 2020-05-06 | 23.10¢ |
Company name | Smith & Nephew |
---|---|
Address | Building 5, Croxley Park, Hatters Lane, Watford, Hertfordshire, United Kingdom, WD18 8YE |
Telephone | +44 (0)1923 477 100 |
Website | http://www.smith-nephew.com |
Director | Position |
---|---|
Dr Deepak Nath | CEO |
Mr John Rogers | CFO |
Mr Marc Owen | Non-Executive Director |
Mr Rupert Soames | Non-Executive Chairman |
Mrs Angie Risley | Senior Independent Director |
Ms Katarzyna Mazur Hofsaess | Independent Non-Executive Director |
Mr Bob White | Independent Non-Executive Director |
Dr John Ma | Independent Non-Executive Director |
Mr Jeremy (Jez) Maiden | Independent Non-Executive Director |
Ms Jo Hallas | Independent Non-Executive Director |
Mr Simon Lowth | Independent Non-Executive Director |
Assets $ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
Intangible asssets and goodwill | 4102 | 4267 | 4387 |
Investments and other non-current assets | 24 | 58 | 198 |
Total non-current assets | 5957 | 6110 | 6496 |
Inventory / work in progress | 2395 | 2205 | 1844 |
Trade and other receivables | 1333 | 1301 | 1290 |
Cash and equivalents | 302 | 350 | 1290 |
Other current assets and asset held for resale | n/a | n/a | n/a |
Total of all assets | 9987 | 9966 | 10920 |
Liabilities $ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Short term liabilities | 2271 | 1715 | 2131 |
Long term liabilities | 2499 | 2992 | 3221 |
Other liabilites / pension etc | n/a | n/a | n/a |
Total of all liabilities | 4770 | 4707 | 5352 |
Net assets $ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Net assets | 5217 | 5259 | 5568 |
Equity $ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Share capital | 175 | 175 | 177 |
Minority interests | n/a | n/a | n/a |
Retained earnings | 4906 | 5026 | 5225 |
Share premium account | 615 | 615 | 614 |
Total equity | 5217 | 5259 | 5568 |
Income $ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Turnover | n/a | n/a | n/a |
Operating profit | 425 | 450 | 593 |
Pre-tax profit | 290 | 235 | 586 |